Diagnostic startup Senzo is developing an at-home COVID-19 test that’s as reliable as a PCR

Published on :

Diagnostic startup Senzo is developing an at-home COVID-19 test that’s as reliable as a PCR
Following a promising early study, the company hopes to take the product to market before the end of the year and add some Philly-based team members. By Paige Gross / STAFF
Join 30,000+ readers who receive daily email updates from Technical.ly
ADVERTISEMENT
About SEER Interactive FIND OUT MORE
TOP ARTICLES
1
How to operationalize your company values
2
RealLIST Connectors: These are the 100 influential leaders to know in Pittsburgh tech
3
RealLIST Connectors 2022: Get to know 22 leaders making Philly’s tech and biz ecosystem stronger
Senzo’s Amplified Lateral Flow COVID-19 test.
(Courtesy photo)
If you’ve headed to a work event, family gathering or crowded space in the last two years, it’s likely you’ve taken an at-home COVID-19 test to check your viral status.
It’s how much of the world is responsibly operating in the “new normal” right now, as we manage the ongoing pandemic while returning to something like pre-2020 life. And one Philly-area startup is hoping its tests can be a part of that system.
Senzo, a point-of-care and self-testing diagnostics company, announced this week it received 100% accuracy ratings of its Amplified…

Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center

Published on :

Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center Manufacturing Innovative Diagnostic Products for Enhancing Patient Healthcare BALTIMORE (PRWEB) FEBRUARY 26, 2021 The LaunchPort™ announced today that Novel Microdevices (http://www.noveldx.com) has moved [….]

ATCC Announces Award of HIV Reagent Program

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines and microorganisms.
Published on :

ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a three-year, $9.86 million task order contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to manage and operate its HIV Reagent Program, formerly known as the AIDS Reagent Program. ATCC is tasked to supply the HIV/AIDS research community with no-cost, high-quality materials supporting the development and evaluation of therapeutics, vaccines, and diagnostics.

2020’s Top 10 Most Read News Stories from the BioHealth Capital Region

Published on :

2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.

5 Questions with John Newby, CEO, Virginia Bio

Published on :

John Newby is the CEO at Virginia Bio, the statewide non-profit trade association for the life science industry. Approximately 300 companies spanning biopharmaceuticals, medical devices, med tech, diagnostics, digital health, bioinformatics, agriculture, and industrial bio and related fields are based in Virginia, mainly clustered around research universities and medical institutions. Virginia Bio is the sole state affiliate and works closely with key national industry organizations BIO, AdvaMed, MDMA, PhRMA and We Work for Health.

Maryland’s Longhorn Vaccines & Diagnostics Set to Launch New Product that Could Revolutionize Molecular Testing

Published on :

Longhorn Vaccines & Diagnostics, which has offices in Bethesda, Maryland, and San Antonio, Texas, has been at the forefront of the battle against COVID-19. And now, the innovative company has released its latest product, PrimeStore Analyte Transport Media (ATM)Ⓡ, which could revolutionize antigen and molecular testing by completely eliminating the need for RNA and DNA extraction.

Good News – Featuring Johns Hopkins, Longhorn Vaccines and Diagnostics – Coca-Cola, and More…

Published on :

Courtesy of Luke Daum, Chief Scientific Officer and Executive VP at Longhorn Vaccines and Diagnostics Good News – Featuring Johns Hopkins, Longhorn Vaccines and Diagnostics, and More… Across the country, [….]

Veteran Owned Diagnostics Supplier Tapped to Help alleviate COVID-19 Sample Collection Shortages

Veteran Owned Diagnostics Supplier Tapped to Help alleviate COVID-19 Sample Collection Shortages
Published on :

Veteran Owned Diagnostics Supplier Tapped to Help alleviate COVID-19 Sample Collection Shortages April 28, 2020 Longhorn Vaccines & Diagnostics, located in Bethesda, Maryland, is a privately-held, veteran-run company that develops [….]